This week we discussed aprocitentan, another endothelin receptor antagonist, this time being explored in the resistant hypertension arena - you know the #TenTweetNephJC drill, if you want a rapid catch up then here’s your place!
Another EMPA-Kidney Tweetorial
Friend of NephJC, Daniel Schwartz does a nice tweetorial on EMPA-Kidney
Don't Stop Me Now!
If you missed the latest NephJC discussion, at least read the highlights here.
You gotta know when to hold’em and know when to fold’em. Review the #TenTweetNephJC for the STOP ACEi Trial, and always hold onto your ACEi.
Flozins strike again!
If you missed the biggest NephJC of the year, at least read the highlights here.
The future for refractory lupus nephritis?
Ten Tweet round up of exciting CAR T trial in patients with SLE discussed last month - check it out while you can!
What does the future look like in ADPKD?
Basic science week - catch up in only Ten Tweets here.
More diuretics = more diuresis
The ADVOR trial (adding acetazolamide in acute heart failure) is covered by #TenTweetNephJC
Is piperacillin-tazobactam nephrotoxic?
The debate continues, but this time with cystatin-C measurements. Read the #TenTweetNephJC summary here!
Speak volumes: #TenTweetNephJC wrap-up on CLASSIC
Intravenous fluids in sepsis - not exactly a rare treatment in a niche condition. Rapidly catch-up on this weeks journal club at the link for the take-home points.
SODIUM-HF: removing 'strict' from 'restriction'
If you missed out of the great #NephJC chat this week you can catch-up with our rapid 10 tweet summary.
Antibiotics and sudden cardiac death: #NephJC Tweetorial Catch-up
Which antibiotics increase risk of sudden death in your patient on haemodialysis? Probably something you should know. Check out our rapid-fire summary tweetorial at the link!
What is dd-cfDNA and how might it help?
Read the #TenTweetNephJC summary of the ADMIRAL study, examining how dd-cfDNA monitoring may help us manage our patients with renal transplants.
Ten Tweets does TESTING 2.0
Did you miss the TESTING reboot discussion? No worries, we have you covered here:
#TenTweetNephJC does CHAP
After CHIP we discussed CHAP. In case you missed it, we have you covered here:
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) June 1, 2022
✳️ Last week's #NephJC in 10 tweets ✳️
Did you miss the latest CHAPter of #NephJC? Join us as we catch you up on the Chronic Hypertension in Pregnancy trial -- the CHAP chat!https://t.co/zdjwgONpt1 pic.twitter.com/4RK5HKulC6
#TenTweetNephJC does CHIP
What the hell is CHIP and why do I need to know about it?
Check out this rapid summary by the talented and creative Tiffany Caza!
Last time dwelling on PD peritonitis guidelines....
With guidelines as big as the latest ISPD whopper you can’t #TenTweetNephJC it - but check out the alternative NephJC summary tweetorial with some take home points below.
#TenTweetNephJC does PLEX in vasculitis
Want to learn more about the latest in using plasma exchange in ANCA-associated vasculitis? (if you’re a nephrologist, of course you do!)
Check out this rapid summary below!
You've been teaching diuretic resistance wrong for decades
This instalment of #TenTweetNephJC - the quickest way to stay up to date - recaps the recent NephJC chat on a mechanistic study investigating diuretic resistance, check it out at the link….
Acetaminophen and hypertension #TenTweetNephJC
The PATH-BP trial dropped - check out the results and the take from the #NephJC chats (in an <2 min summary)
Xenotransplantation summary tweetorial
You’ll have heard about the pig xenotransplant that did NOT show hyperacute rejection - check out the summary tweetorial of the need-to-know points from the study here.